Identification and characterization of the intercellular adhesion molecule-2 gene as a novel p53 target

Area of Science:

• Molecular Biology
• Cancer Biology
• Cell Signaling

Background:

• The p53 tumor suppressor is crucial for maintaining genome stability and preventing cancer by inducing cell cycle arrest and apoptosis.
• Intercellular adhesion molecule-2 (ICAM2) is a cell surface glycoprotein involved in cell adhesion and immune responses.

Purpose of the Study:

• To investigate the transcriptional regulation of ICAM2 by p53 and its functional role in cancer.
• To explore the association between ICAM2 expression, p53 status, and patient survival in human cancers.

Main Methods:

• Identification of p53 binding sites within the ICAM2 gene promoter.
• Analysis of ICAM2 induction by p53 family members and DNA damage.
• Functional assays assessing the impact of ICAM2 expression on cancer cell migration and invasion.
• Western blot analysis to evaluate extracellular signal-regulated kinase (ERK) phosphorylation.
• Analysis of ICAM2 expression in human cancer tissues with varying p53 mutation status.

Main Results:

• p53 transcriptionally activates ICAM2 expression in a p53-dependent manner, with a functional p53 binding site identified in the ICAM2 gene.
• Ectopic expression of ICAM2 inhibited cancer cell migration and invasion, mediated by the suppression of ERK signaling.
• ICAM2 is significantly underexpressed in human cancers with mutant p53 compared to those with wild-type p53.
• Decreased ICAM2 expression correlates with poor patient survival across multiple cancer types.

Conclusions:

• p53-induced ICAM2 acts as a tumor suppressor by inhibiting cancer cell migration and invasion, partly through the suppression of ERK signaling.
• ICAM2 represents a potential therapeutic target and a prognostic biomarker in cancer, particularly in tumors with p53 mutations.